Inhibition of nuclear factor-κB activation improves non-nitric oxide-mediated cutaneous microvascular function in reproductive-aged healthy women

The transcription factor nuclear factor-κB (NF-κB) regulates multiple aspects of innate and adaptive immunity by encoding for genes that participate in inflammation and impact endothelial function following NF-κB inhibition with salsalate treatment. Our results show that cutaneous microvascular func...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of physiology. Heart and circulatory physiology Vol. 327; no. 2; pp. H364 - H369
Main Authors Content, Virginia G., Williams, Auni C., Alexander, Lacy M.
Format Journal Article
LanguageEnglish
Published United States American Physiological Society 01.08.2024
SeriesVascular Biology and Microcirculation
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The transcription factor nuclear factor-κB (NF-κB) regulates multiple aspects of innate and adaptive immunity by encoding for genes that participate in inflammation and impact endothelial function following NF-κB inhibition with salsalate treatment. Our results show that cutaneous microvascular function is increased through non-nitric oxide (NO)-dependent mechanisms following salsalate treatment in reproductive-aged healthy women. The transcriptional regulator nuclear factor-κB (NF-κB) is a mediator of endothelial dysfunction. Inhibiting NF-κB with salsalate is used to investigate inflammatory mechanisms contributing to accelerated cardiovascular disease risk. However, in the absence of disease, inhibition of NF-κB can impact redox mechanisms, resulting in paradoxically decreased endothelial function. This study aimed to measure microvascular endothelial function during inhibition of the transcriptional regulator NF-κB in reproductive-aged healthy women. In a randomized, single-blind, crossover, placebo-controlled design, nine healthy women were randomly assigned oral salsalate (1,500 mg, twice daily) or placebo treatments for 5 days. Subjects underwent graded perfusion with the endothelium-dependent agonist acetylcholine (ACh, 10 −10 to 10 −1 M, 33°C) alone and in combination with 15 mM N G -nitro-l-arginine methyl ester [l-NAME; nonselective nitric oxide (NO) synthase inhibitor] through intradermal microdialysis. Laser-Doppler flux was measured over each microdialysis site, and cutaneous vascular conductance (CVC) was calculated as flux divided by mean arterial pressure and normalized to site-specific maximum (CVC %max ; 28 mM sodium nitroprusside + 43°C). The l-NAME sensitive component was calculated as the difference between the areas under the dose-response curves. During the placebo and salsalate treatments, the l-NAME sites were reduced compared with the control sites (both P < 0.0001). Across treatments, there was a significant difference between the control and l-NAME sites, where both sites shifted upward following salsalate treatment (both P < 0.0001), whereas the l-NAME-sensitive component was not different ( P = 0.94). These data demonstrate that inhibition of the transcriptional regulator NF-κB improves cutaneous microvascular function in reproductive-aged healthy women through non-NO-dependent mechanisms. NEW & NOTEWORTHY The transcription factor nuclear factor-κB (NF-κB) regulates multiple aspects of innate and adaptive immunity by encoding for genes that participate in inflammation and impact endothelial function following NF-κB inhibition with salsalate treatment. Our results show that cutaneous microvascular function is increased through non-nitric oxide (NO)-dependent mechanisms following salsalate treatment in reproductive-aged healthy women.
AbstractList The transcriptional regulator nuclear factor-κB (NF-κB) is a mediator of endothelial dysfunction. Inhibiting NF-κB with salsalate is used to investigate inflammatory mechanisms contributing to accelerated cardiovascular disease risk. However, in the absence of disease, inhibition of NF-κB can impact redox mechanisms, resulting in paradoxically decreased endothelial function. This study aimed to measure microvascular endothelial function during inhibition of the transcriptional regulator NF-κB in reproductive-aged healthy women. In a randomized, single-blind, crossover, placebo-controlled design, nine healthy women were randomly assigned oral salsalate (1,500 mg, twice daily) or placebo treatments for 5 days. Subjects underwent graded perfusion with the endothelium-dependent agonist acetylcholine (ACh, 10-10 to 10-1 M, 33°C) alone and in combination with 15 mM NG-nitro-l-arginine methyl ester [l-NAME; nonselective nitric oxide (NO) synthase inhibitor] through intradermal microdialysis. Laser-Doppler flux was measured over each microdialysis site, and cutaneous vascular conductance (CVC) was calculated as flux divided by mean arterial pressure and normalized to site-specific maximum (CVC%max; 28 mM sodium nitroprusside + 43°C). The l-NAME sensitive component was calculated as the difference between the areas under the dose-response curves. During the placebo and salsalate treatments, the l-NAME sites were reduced compared with the control sites (both P < 0.0001). Across treatments, there was a significant difference between the control and l-NAME sites, where both sites shifted upward following salsalate treatment (both P < 0.0001), whereas the l-NAME-sensitive component was not different (P = 0.94). These data demonstrate that inhibition of the transcriptional regulator NF-κB improves cutaneous microvascular function in reproductive-aged healthy women through non-NO-dependent mechanisms.NEW & NOTEWORTHY The transcription factor nuclear factor-κB (NF-κB) regulates multiple aspects of innate and adaptive immunity by encoding for genes that participate in inflammation and impact endothelial function following NF-κB inhibition with salsalate treatment. Our results show that cutaneous microvascular function is increased through non-nitric oxide (NO)-dependent mechanisms following salsalate treatment in reproductive-aged healthy women.The transcriptional regulator nuclear factor-κB (NF-κB) is a mediator of endothelial dysfunction. Inhibiting NF-κB with salsalate is used to investigate inflammatory mechanisms contributing to accelerated cardiovascular disease risk. However, in the absence of disease, inhibition of NF-κB can impact redox mechanisms, resulting in paradoxically decreased endothelial function. This study aimed to measure microvascular endothelial function during inhibition of the transcriptional regulator NF-κB in reproductive-aged healthy women. In a randomized, single-blind, crossover, placebo-controlled design, nine healthy women were randomly assigned oral salsalate (1,500 mg, twice daily) or placebo treatments for 5 days. Subjects underwent graded perfusion with the endothelium-dependent agonist acetylcholine (ACh, 10-10 to 10-1 M, 33°C) alone and in combination with 15 mM NG-nitro-l-arginine methyl ester [l-NAME; nonselective nitric oxide (NO) synthase inhibitor] through intradermal microdialysis. Laser-Doppler flux was measured over each microdialysis site, and cutaneous vascular conductance (CVC) was calculated as flux divided by mean arterial pressure and normalized to site-specific maximum (CVC%max; 28 mM sodium nitroprusside + 43°C). The l-NAME sensitive component was calculated as the difference between the areas under the dose-response curves. During the placebo and salsalate treatments, the l-NAME sites were reduced compared with the control sites (both P < 0.0001). Across treatments, there was a significant difference between the control and l-NAME sites, where both sites shifted upward following salsalate treatment (both P < 0.0001), whereas the l-NAME-sensitive component was not different (P = 0.94). These data demonstrate that inhibition of the transcriptional regulator NF-κB improves cutaneous microvascular function in reproductive-aged healthy women through non-NO-dependent mechanisms.NEW & NOTEWORTHY The transcription factor nuclear factor-κB (NF-κB) regulates multiple aspects of innate and adaptive immunity by encoding for genes that participate in inflammation and impact endothelial function following NF-κB inhibition with salsalate treatment. Our results show that cutaneous microvascular function is increased through non-nitric oxide (NO)-dependent mechanisms following salsalate treatment in reproductive-aged healthy women.
The transcriptional regulator nuclear factor-κB (NF-κB) is a mediator of endothelial dysfunction. Inhibiting NF-κB with salsalate is used to investigate inflammatory mechanisms contributing to accelerated cardiovascular disease risk. However, in the absence of disease, inhibition of NF-κB can impact redox mechanisms, resulting in paradoxically decreased endothelial function. This study aimed to measure microvascular endothelial function during inhibition of the transcriptional regulator NF-κB in reproductive-aged healthy women. In a randomized, single-blind, crossover, placebo-controlled design, nine healthy women were randomly assigned oral salsalate (1,500 mg, twice daily) or placebo treatments for 5 days. Subjects underwent graded perfusion with the endothelium-dependent agonist acetylcholine (ACh, 10 −10 to 10 −1 M, 33°C) alone and in combination with 15 mM N G -nitro- l -arginine methyl ester [ l -NAME; nonselective nitric oxide (NO) synthase inhibitor] through intradermal microdialysis. Laser-Doppler flux was measured over each microdialysis site, and cutaneous vascular conductance (CVC) was calculated as flux divided by mean arterial pressure and normalized to site-specific maximum (CVC %max ; 28 mM sodium nitroprusside + 43°C). The l -NAME sensitive component was calculated as the difference between the areas under the dose-response curves. During the placebo and salsalate treatments, the l -NAME sites were reduced compared with the control sites (both P < 0.0001). Across treatments, there was a significant difference between the control and l -NAME sites, where both sites shifted upward following salsalate treatment (both P < 0.0001), whereas the l -NAME-sensitive component was not different ( P = 0.94). These data demonstrate that inhibition of the transcriptional regulator NF-κB improves cutaneous microvascular function in reproductive-aged healthy women through non-NO-dependent mechanisms. NEW & NOTEWORTHY The transcription factor nuclear factor-κB (NF-κB) regulates multiple aspects of innate and adaptive immunity by encoding for genes that participate in inflammation and impact endothelial function following NF-κB inhibition with salsalate treatment. Our results show that cutaneous microvascular function is increased through non-nitric oxide (NO)-dependent mechanisms following salsalate treatment in reproductive-aged healthy women.
The transcriptional regulator nuclear factor-κB (NF-κB) is a mediator of endothelial dysfunction. Inhibiting NF-κB with salsalate is used to investigate inflammatory mechanisms contributing to accelerated cardiovascular disease risk. However, in the absence of disease, inhibition of NF-κB can impact redox mechanisms, resulting in paradoxically decreased endothelial function. This study aimed to measure microvascular endothelial function during inhibition of the transcriptional regulator NF-κB in reproductive-aged healthy women. In a randomized, single-blind, crossover, placebo-controlled design, nine healthy women were randomly assigned oral salsalate (1,500 mg, twice daily) or placebo treatments for 5 days. Subjects underwent graded perfusion with the endothelium-dependent agonist acetylcholine (ACh, 10−10 to 10−1 M, 33°C) alone and in combination with 15 mM NG-nitro-l-arginine methyl ester [l-NAME; nonselective nitric oxide (NO) synthase inhibitor] through intradermal microdialysis. Laser-Doppler flux was measured over each microdialysis site, and cutaneous vascular conductance (CVC) was calculated as flux divided by mean arterial pressure and normalized to site-specific maximum (CVC%max; 28 mM sodium nitroprusside + 43°C). The l-NAME sensitive component was calculated as the difference between the areas under the dose-response curves. During the placebo and salsalate treatments, the l-NAME sites were reduced compared with the control sites (both P < 0.0001). Across treatments, there was a significant difference between the control and l-NAME sites, where both sites shifted upward following salsalate treatment (both P < 0.0001), whereas the l-NAME-sensitive component was not different (P = 0.94). These data demonstrate that inhibition of the transcriptional regulator NF-κB improves cutaneous microvascular function in reproductive-aged healthy women through non-NO-dependent mechanisms.
The transcriptional regulator nuclear factor-κB (NF-κB) is a mediator of endothelial dysfunction. Inhibiting NF-κB with salsalate is used to investigate inflammatory mechanisms contributing to accelerated cardiovascular disease risk. However, in the absence of disease, inhibition of NF-κB can impact redox mechanisms, resulting in paradoxically decreased endothelial function. This study aimed to measure microvascular endothelial function during inhibition of the transcriptional regulator NF-κB in reproductive-aged healthy women. In a randomized, single-blind, crossover, placebo-controlled design, nine healthy women were randomly assigned oral salsalate (1,500 mg, twice daily) or placebo treatments for 5 days. Subjects underwent graded perfusion with the endothelium-dependent agonist acetylcholine (ACh, 10 to 10 M, 33°C) alone and in combination with 15 mM -nitro-l-arginine methyl ester [l-NAME; nonselective nitric oxide (NO) synthase inhibitor] through intradermal microdialysis. Laser-Doppler flux was measured over each microdialysis site, and cutaneous vascular conductance (CVC) was calculated as flux divided by mean arterial pressure and normalized to site-specific maximum (CVC ; 28 mM sodium nitroprusside + 43°C). The l-NAME sensitive component was calculated as the difference between the areas under the dose-response curves. During the placebo and salsalate treatments, the l-NAME sites were reduced compared with the control sites (both < 0.0001). Across treatments, there was a significant difference between the control and l-NAME sites, where both sites shifted upward following salsalate treatment (both < 0.0001), whereas the l-NAME-sensitive component was not different ( = 0.94). These data demonstrate that inhibition of the transcriptional regulator NF-κB improves cutaneous microvascular function in reproductive-aged healthy women through non-NO-dependent mechanisms. The transcription factor nuclear factor-κB (NF-κB) regulates multiple aspects of innate and adaptive immunity by encoding for genes that participate in inflammation and impact endothelial function following NF-κB inhibition with salsalate treatment. Our results show that cutaneous microvascular function is increased through non-nitric oxide (NO)-dependent mechanisms following salsalate treatment in reproductive-aged healthy women.
The transcription factor nuclear factor-κB (NF-κB) regulates multiple aspects of innate and adaptive immunity by encoding for genes that participate in inflammation and impact endothelial function following NF-κB inhibition with salsalate treatment. Our results show that cutaneous microvascular function is increased through non-nitric oxide (NO)-dependent mechanisms following salsalate treatment in reproductive-aged healthy women. The transcriptional regulator nuclear factor-κB (NF-κB) is a mediator of endothelial dysfunction. Inhibiting NF-κB with salsalate is used to investigate inflammatory mechanisms contributing to accelerated cardiovascular disease risk. However, in the absence of disease, inhibition of NF-κB can impact redox mechanisms, resulting in paradoxically decreased endothelial function. This study aimed to measure microvascular endothelial function during inhibition of the transcriptional regulator NF-κB in reproductive-aged healthy women. In a randomized, single-blind, crossover, placebo-controlled design, nine healthy women were randomly assigned oral salsalate (1,500 mg, twice daily) or placebo treatments for 5 days. Subjects underwent graded perfusion with the endothelium-dependent agonist acetylcholine (ACh, 10 −10 to 10 −1 M, 33°C) alone and in combination with 15 mM N G -nitro-l-arginine methyl ester [l-NAME; nonselective nitric oxide (NO) synthase inhibitor] through intradermal microdialysis. Laser-Doppler flux was measured over each microdialysis site, and cutaneous vascular conductance (CVC) was calculated as flux divided by mean arterial pressure and normalized to site-specific maximum (CVC %max ; 28 mM sodium nitroprusside + 43°C). The l-NAME sensitive component was calculated as the difference between the areas under the dose-response curves. During the placebo and salsalate treatments, the l-NAME sites were reduced compared with the control sites (both P < 0.0001). Across treatments, there was a significant difference between the control and l-NAME sites, where both sites shifted upward following salsalate treatment (both P < 0.0001), whereas the l-NAME-sensitive component was not different ( P = 0.94). These data demonstrate that inhibition of the transcriptional regulator NF-κB improves cutaneous microvascular function in reproductive-aged healthy women through non-NO-dependent mechanisms. NEW & NOTEWORTHY The transcription factor nuclear factor-κB (NF-κB) regulates multiple aspects of innate and adaptive immunity by encoding for genes that participate in inflammation and impact endothelial function following NF-κB inhibition with salsalate treatment. Our results show that cutaneous microvascular function is increased through non-nitric oxide (NO)-dependent mechanisms following salsalate treatment in reproductive-aged healthy women.
Author Williams, Auni C.
Content, Virginia G.
Alexander, Lacy M.
Author_xml – sequence: 1
  givenname: Virginia G.
  orcidid: 0000-0002-5115-3256
  surname: Content
  fullname: Content, Virginia G.
  organization: Noll Laboratory, Department of Kinesiology, The Pennsylvania State University, University Park, Pennsylvania, United States
– sequence: 2
  givenname: Auni C.
  orcidid: 0000-0001-5439-9182
  surname: Williams
  fullname: Williams, Auni C.
  organization: Noll Laboratory, Department of Kinesiology, The Pennsylvania State University, University Park, Pennsylvania, United States
– sequence: 3
  givenname: Lacy M.
  orcidid: 0000-0002-1294-8582
  surname: Alexander
  fullname: Alexander, Lacy M.
  organization: Noll Laboratory, Department of Kinesiology, The Pennsylvania State University, University Park, Pennsylvania, United States, Center for Healthy Aging, The Pennsylvania State University, University Park, Pennsylvania, United States
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38847757$$D View this record in MEDLINE/PubMed
BookMark eNpdktFuFCEUholpY7fVJzAxJN54MysMzDBcGW2qNmnSm_aaAHOmy2YGVmBW-xo-jg_RZ5LdbRv1CpLz8eU_h3OKjnzwgNAbSpaUNvUHvd6sQMe8JKQmfFmTmr9Ai1KpK9oweYQWhLWsailrTtBpSmtCSCNa9hKdsK7jQjRigX5d-pUzLrvgcRiwn-1YnHjQNodYPfz-jMvNbfUecNMmhi0kXJJU3uXoLA4_XQ_VBL3TGXps56w9hDnhydkC62TncSecvT04PI5QNP2880Kl78qr0seYV_f4R5jAv0LHgx4TvH48z9Dtl4ub82_V1fXXy_NPV5WtW5krA7U2lLRNZ7pWio5bkI00tLFScgOaG6pJr62RRhApetmTgWptmBgMMEHYGfp48G5mU_Jb8DnqUW2im3S8V0E79W_Fu5W6C1tFKee8rttieP9oiOH7DCmrySUL43gYgWIlnexIs0ff_Yeuwxx96a9QkrSljZYX6u3fkZ6zPP1XAdgBKLNNKcLwjFCidluhnrZC7bdC7baC_QEWMbJq
Cites_doi 10.3389/fphys.2020.596507
10.1038/23948
10.1016/j.preghy.2021.12.010
10.1161/01.CIR.101.6.676
10.1017/S0007114516001835
10.1161/JAHA.113.000609
10.1152/ajpregu.00049.2020
10.1152/ajpheart.00368.2021
10.1186/cc9257
10.1161/CIRCULATIONAHA.105.602532
10.1210/jcem.80.3.7883838
10.1007/s10787-023-01242-9
10.2165/00003088-198510020-00004
10.1124/mol.57.4.797
10.1152/japplphysiol.00427.2020
10.1093/emboj/20.21.6008
10.1124/pr.117.014050
10.1038/sj.onc.1209954
10.1249/01.mss.0000150075.81511.fe
10.3389/fragi.2021.727416
10.1002/j.1552-4604.1981.tb01740.x
10.1097/00005344-199322008-00039
10.1111/micc.12490
10.1152/ajpheart.00643.2021
10.1161/01.HYP.33.1.581
10.1126/science.8052854
10.1152/ajpregu.00269.2014
10.1016/0010-7824(95)00210-2
10.1161/CIRCULATIONAHA.108.804294
10.1016/j.mvr.2022.104421
10.1152/ajpheart.00602.2021
10.1113/jphysiol.2009.178822
10.1007/s00592-011-0329-2
10.1016/s0026-0495(00)91039-4
10.1161/01.atv.0000051384.43104.fc
10.1074/jbc.M103702200
ContentType Journal Article
Copyright Copyright American Physiological Society Aug 2024
Copyright © 2024 the American Physiological Society. 2024 American Physiological Society
Copyright_xml – notice: Copyright American Physiological Society Aug 2024
– notice: Copyright © 2024 the American Physiological Society. 2024 American Physiological Society
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7QR
7TS
7U7
8FD
C1K
FR3
P64
7X8
5PM
DOI 10.1152/ajpheart.00204.2024
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Physical Education Index
Toxicology Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Technology Research Database
Toxicology Abstracts
Chemoreception Abstracts
Engineering Research Database
Calcium & Calcified Tissue Abstracts
Physical Education Index
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

Technology Research Database
MEDLINE
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
DocumentTitleAlternate NF-κB INHIBITION AND NITRIC OXIDE-INDEPENDENT MECHANISMS
EISSN 1522-1539
EndPage H369
ExternalDocumentID PMC11444226
38847757
10_1152_ajpheart_00204_2024
Genre Randomized Controlled Trial
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)
  grantid: R01 HL161000-02S2
– fundername: NHLBI NIH HHS
  grantid: R01 HL161000
– fundername: NHLBI NIH HHS
  grantid: F31 HL170616
– fundername: HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)
  grantid: F31 HL170616-0
GroupedDBID ---
23M
2WC
39C
4.4
53G
5GY
6J9
AAFWJ
AAYXX
ABJNI
ACBEA
ACIWK
ACPRK
ADBBV
AENEX
AFRAH
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BKKCC
BKOMP
BTFSW
CITATION
E3Z
EBS
EMOBN
F5P
H13
ITBOX
KQ8
OK1
P2P
PQQKQ
RAP
RHI
RPL
RPRKH
TR2
UKR
WH7
WOQ
XSW
YSK
~02
5VS
CGR
CUY
CVF
ECM
EIF
GX1
NPM
W8F
7QP
7QR
7TS
7U7
8FD
C1K
FR3
P64
7X8
5PM
ID FETCH-LOGICAL-c269t-be2ab10658b869784ce959b15c994bea4b1a0dacb9b7097d9d0f1aab37fbe3703
ISSN 0363-6135
1522-1539
IngestDate Thu Aug 21 18:33:20 EDT 2025
Fri Jul 11 02:34:58 EDT 2025
Mon Jun 30 16:45:04 EDT 2025
Sun Aug 03 01:52:46 EDT 2025
Tue Jul 01 02:28:02 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords NO-independent vasodilation
NF-κB
microdialysis
inflammation
salsalate
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c269t-be2ab10658b869784ce959b15c994bea4b1a0dacb9b7097d9d0f1aab37fbe3703
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
ORCID 0000-0001-5439-9182
0000-0002-1294-8582
0000-0002-5115-3256
PMID 38847757
PQID 3090665864
PQPubID 48261
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_11444226
proquest_miscellaneous_3065980526
proquest_journals_3090665864
pubmed_primary_38847757
crossref_primary_10_1152_ajpheart_00204_2024
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-08-01
PublicationDateYYYYMMDD 2024-08-01
PublicationDate_xml – month: 08
  year: 2024
  text: 2024-08-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Bethesda
– name: Rockville, MD
PublicationSeriesTitle Vascular Biology and Microcirculation
PublicationTitle American journal of physiology. Heart and circulatory physiology
PublicationTitleAlternate Am J Physiol Heart Circ Physiol
PublicationYear 2024
Publisher American Physiological Society
Publisher_xml – name: American Physiological Society
References B20
B21
B22
B23
B24
B25
B26
B27
B28
B29
Moncada S (B1) 1991; 43
B30
B31
B10
B32
B11
B33
B12
B34
B13
B35
B14
B36
B15
B37
B16
B38
B17
B18
B19
B3
B4
B5
B6
B7
B8
B9
Hadi HA (B2) 2005; 1
References_xml – ident: B35
  doi: 10.3389/fphys.2020.596507
– ident: B6
  doi: 10.1038/23948
– ident: B10
  doi: 10.1016/j.preghy.2021.12.010
– ident: B24
  doi: 10.1161/01.CIR.101.6.676
– ident: B27
  doi: 10.1017/S0007114516001835
– volume: 43
  start-page: 109
  year: 1991
  ident: B1
  publication-title: Pharmacol Rev
– ident: B13
  doi: 10.1161/JAHA.113.000609
– ident: B32
  doi: 10.1152/ajpregu.00049.2020
– ident: B37
  doi: 10.1152/ajpheart.00368.2021
– ident: B31
  doi: 10.1186/cc9257
– ident: B4
  doi: 10.1161/CIRCULATIONAHA.105.602532
– ident: B26
  doi: 10.1210/jcem.80.3.7883838
– ident: B12
  doi: 10.1007/s10787-023-01242-9
– ident: B17
  doi: 10.2165/00003088-198510020-00004
– ident: B11
  doi: 10.1124/mol.57.4.797
– ident: B16
  doi: 10.1152/japplphysiol.00427.2020
– ident: B29
  doi: 10.1093/emboj/20.21.6008
– ident: B30
  doi: 10.1124/pr.117.014050
– volume: 1
  start-page: 183
  year: 2005
  ident: B2
  publication-title: Vasc Health Risk Manag
– ident: B5
  doi: 10.1038/sj.onc.1209954
– ident: B36
  doi: 10.1249/01.mss.0000150075.81511.fe
– ident: B15
  doi: 10.3389/fragi.2021.727416
– ident: B18
  doi: 10.1002/j.1552-4604.1981.tb01740.x
– ident: B20
  doi: 10.1097/00005344-199322008-00039
– ident: B19
  doi: 10.1111/micc.12490
– ident: B9
  doi: 10.1152/ajpheart.00643.2021
– ident: B21
  doi: 10.1161/01.HYP.33.1.581
– ident: B7
  doi: 10.1126/science.8052854
– ident: B14
  doi: 10.1152/ajpregu.00269.2014
– ident: B34
  doi: 10.1016/0010-7824(95)00210-2
– ident: B8
  doi: 10.1161/CIRCULATIONAHA.108.804294
– ident: B28
  doi: 10.1016/j.mvr.2022.104421
– ident: B38
  doi: 10.1152/ajpheart.00602.2021
– ident: B33
  doi: 10.1113/jphysiol.2009.178822
– ident: B22
  doi: 10.1007/s00592-011-0329-2
– ident: B25
  doi: 10.1016/s0026-0495(00)91039-4
– ident: B3
  doi: 10.1161/01.atv.0000051384.43104.fc
– ident: B23
  doi: 10.1074/jbc.M103702200
SSID ssj0005763
Score 2.4540029
Snippet The transcription factor nuclear factor-κB (NF-κB) regulates multiple aspects of innate and adaptive immunity by encoding for genes that participate in...
The transcriptional regulator nuclear factor-κB (NF-κB) is a mediator of endothelial dysfunction. Inhibiting NF-κB with salsalate is used to investigate...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage H364
SubjectTerms Acetylcholine - pharmacology
Adult
Arginine
Blood pressure
Cardiovascular diseases
Cross-Over Studies
Endothelium
Endothelium, Vascular - drug effects
Endothelium, Vascular - metabolism
Enzyme Inhibitors - pharmacology
Female
Health risks
Healthy Volunteers
Humans
Microcirculation - drug effects
Microdialysis
Microvasculature
Microvessels - drug effects
Microvessels - metabolism
NF-kappa B - metabolism
NF-κB protein
NG-Nitroarginine methyl ester
NG-Nitroarginine Methyl Ester - pharmacology
Nitric oxide
Nitric Oxide - metabolism
Placebos
Regional Blood Flow - drug effects
Salicylates - pharmacology
Short Report
Single-Blind Method
Skin - blood supply
Skin - drug effects
Skin - metabolism
Sodium nitroprusside
Transcription activation
Vasodilation - drug effects
Vasodilator Agents - pharmacology
Young Adult
Title Inhibition of nuclear factor-κB activation improves non-nitric oxide-mediated cutaneous microvascular function in reproductive-aged healthy women
URI https://www.ncbi.nlm.nih.gov/pubmed/38847757
https://www.proquest.com/docview/3090665864
https://www.proquest.com/docview/3065980526
https://pubmed.ncbi.nlm.nih.gov/PMC11444226
Volume 327
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dbtMwFLbKkKbdINj4KQxkJMYVKflx0viynYYKaAikDe0uimOXBalpFVqJ8hg8DuIZeCbOsR0nXYcE3ERVbMVRvy_H59jnfCbkmZQJUz6XHs-HvsdCEXsilIUnpwr8OV-xQmt3nr5LJufszUV80ev97GQtrZZiUHy7tq7kf1CFe4ArVsn-A7LuoXADfgO-cAWE4fpXGL-uLktRNj5fhdLEeW2P0PGOjk-OxqOxVssw665YElnPUWYWYn4PvmXMop9_LaXydAEJOp_FCrxFhXmxM0zVc4mqOP81eZEohKl1YsFSemCPpK2mXBs9h66_6zaEOgoVejFFr-YPsAqqNjnuRVnjSHrPv-3htkhQRMtIJHws608l1pK5U8G6a0ajVVW2K7-ufMeUgBdru_hrlzlC5pLsYJayphnCZrDPvGu7IyMsYEkadizxJDLq6NtTRIySs_nnBZ4Yvhzo6uABjtjtDTgvZpo1UQrz99CIaF9R5m6abpCbIQQpeH7G2w-tVj1EcpHVuYIxX14z4h7ZbZ6x6RZtxTpXU3Y7PtDZbXLLBi90ZJh4h_RUtU8ORhWgNlvT5_S9w22f7J7arI0D8r3lKZ1PqeUptTz99WNMW47ShqO05Sjd5Ch1HKUbHKUNR2lZ0S2OUstRqjl6l5y_Ojk7nnj2LBCvCBO-9IQKcxGgvyzShA9TVigecxHEBedMqJyJIPdlXgguhj4fSi79aZDnIhpOhYpgWrtHduC91QNCoyCPIslDNU0UY1LmsvDzQIgUrJME29QnLxoosoWRfMl0qByHWQNipkHMEMQ-OWzgyuy39CWLfI57mmkCzU9dM1hu3I4zfxH0SWKOJ4okfXLfoOvGa2jRJ-kG7q4DqsJvtlTlpVaHDwLGsDz-4R8f-ojstV_YIdlZ1iv1GFzrpXiiGfwb337eLg
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Inhibition+of+nuclear+factor-%CE%BAB+activation+improves+non-nitric+oxide-mediated+cutaneous+microvascular+function+in+reproductive-aged+healthy+women&rft.jtitle=American+journal+of+physiology.+Heart+and+circulatory+physiology&rft.au=Content%2C+Virginia+G&rft.au=Williams%2C+Auni+C&rft.au=Alexander%2C+Lacy+M&rft.date=2024-08-01&rft.eissn=1522-1539&rft.volume=327&rft.issue=2&rft.spage=H364&rft_id=info:doi/10.1152%2Fajpheart.00204.2024&rft_id=info%3Apmid%2F38847757&rft.externalDocID=38847757
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0363-6135&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0363-6135&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0363-6135&client=summon